Is NVAX a good stock to buy? We came across a bullish thesis on Novavax, Inc. on BioEquity Watch’s Substack. In this article, ...

Is IDYA a good stock to buy? We came across a bullish thesis on IDEAYA Biosciences, Inc. on Valueinvestorsclub.com by ...

Good afternoon, everyone, and welcome to IonQ's First Quarter 2026 Earnings Call. My name is Hanley Donofrio, and I am the Investor Relations Director here at IonQ. I'm pleased to be joined on today's ...

Pancreatic cancer remains one of the most difficult cancers to treat, with many patients facing a high risk of recurrence ...

ME Therapeutics Holdings Inc. ("ME Therapeutics" or the "Company") , a publicly listed biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel Prize–winning technology is being adapted to fight cancer, with mRNA vaccines in ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help ...

At ASGCT, the company will share data showing that its RNA achieves higher, more durable protein expression compared to other ...

Moderna is launching a large-scale clinical trial of a shot to combat bird flu in humans after Health and Human Services Secretary Robert F. Kennedy Jr.’s department had canceled hundreds of millions ...

EDITOR’S NOTE: This story was reported in collaboration with the Global Health Reporting Center with support from the Pulitzer Center. Vita Sara Blechner’s life changed on a Saturday afternoon. The ...